Daiwa Securities Group
RVLP

Daiwa Securities Group’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Daiwa Securities Group’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-140
Closed – – 1469
2021
Q3 		$0 Hold
140
– – ﹤0.01% 1353
2021
Q2 		$0 Hold
140
– – ﹤0.01% 1297
2021
Q1 		$0 Hold
140
– – ﹤0.01% 1295
2020
Q4 		$1K Sell
140
-153
-52% -$882 ﹤0.01% 1229
2020
Q3 		$2K Hold
293
– – ﹤0.01% 1152
2020
Q2 		$32K Hold
293
– – ﹤0.01% 990
2020
Q1 		$1K Buy
+293
New +$1.56K ﹤0.01% 1203

Other funds holding RVLP

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
RA
Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Daiwa Securities Group's RVLP Position: Q4 2021 in Review

Daiwa Securities Group sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2021, closing a stake of 140 shares.

Daiwa Securities Group first reported a position in RVLP in Q1 2020 and held it in 7 quarters. The position peaked at $32K in Q2 2020. 31 funds tracked by Wall St. Rank hold RVLP as of Q4 2021.

  • Daiwa Securities Group reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2021 after selling out during the quarter.
  • Daiwa Securities Group sold 140 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2021.
  • Daiwa Securities Group first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q1 2020 and held it in 7 quarters.
  • Daiwa Securities Group's RVL Pharmaceuticals plc Ordinary Shares position peaked at $32K in Q2 2020.
  • 31 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2021.

Based on Daiwa Securities Group's 13F filing for Q4 2021, filed 3 Feb 2022.